Attending C3 with fellow compounding professionals means a stronger community for compounding pharmacies. It means meeting folks like Max, Lisa, and Denise, three pharmacists who recently completed C3.  We asked them a few questions about their C3 experience and this is what they had to say.

Devaki Lindsey Berkson, a well-respected nutritionist and hormone research expert, and what she has to say might just change the way you think about the "cuddle chemical"--Oxytocin.

Mike and Seb had a tremendous January, meeting with industry leaders Dr. Pamela Wartian Smith, Saad Dinno, and Bryan Prescott. You can connect to the best pharmacy compounding podcast on the web right here!

January updates for PCCA Play! Doctor Pamela W. Smith explains the importance of hormones and GI health and how they affect the skin. Also, a sneak peek at Doctor Valcinir Bedin's Chemical Peels and Resurfacing lecture that goes live on January 24th.

We’re excited that patients and physicians now have access to Azelastine Hydrochloride USP as an ingredient option in compounded medications. There are some commercial products available, including a combination product, but when those items don’t fit the specific needs of patients, we need to put on our thinking caps and start looking for other options for them. We’re sure that you compounders out there can come up with a few of your own as well.

By Maria Carvalho, PharmD, MRPharmS, PhD. She is the Manager of PCCA Science.

Pain affects more Americans than diabetes, heart disease and cancer combined. It represents an important public health issue that is associated with a wide range of injury and disease. As a result, an estimated 20% of patients with chronic pain receive an opioid prescription when visiting physician offices, and rates of opioid prescribing have grown significantly, in particular for family practice, general practice and internal medicine.

Vote for Your Favorite Compounding Kiki Challenge Video

Welcome to our blog. This will be a place for anyone involved in the pharmacy compounding industry to engage with shareable content that affects compounders, health care practitioners and patients.